Biggest News Aggregation in the World
📰 Titles Released News

Titles Released News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Titles Released. Real-time updates on events, politics, business and more.

ASCO 2023: RemeGen Exhibits Promising Results of Disitamab Vedotin in Bladder Cancer

YANTAI, China, June 5, 2023 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, announced the latest clinical research results on disitamab vedotin (RC48) at this year's American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 2-6, 2023, in Chicago. Researchers tested disitamab vedotin and toripalimab in combination on...
United States Czech Republic Fang Jianmin Guo Jun Remegen Co University Cancer Hospital

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science